Decitabine reverses innate immune gene suppression in rare melanomas
Morgan L. MacBeth, Stacey M. Bagby, Jessica S.W. Borgers, Jacqueline A. Turner, Kelsey C. Anderson, Phaedra A. Whitty, Sarah J. Hartman, Beteleham Yacob, Vito W. Rebecca, Eduardo Dávila, Todd M. Pitts, Theresa Michelle Medina, Sapna Pradyuman Patel, Martin D. McCarter, William Allen Robinson, , Kasey L. Couts
This study identifies immune evasion mechanisms in rare melanomas and shows that decitabine reactivates innate immune pathways, improving immune responsiveness.
Molecular Cancer Therapeutics · Jul 13, 2026Peer-reviewedCancer Biology